[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ATE165811T1 - Zwischenprodukte für die herstellung von endothelinrezeptor-antagonist-triterpen-derivat n - Google Patents

Zwischenprodukte für die herstellung von endothelinrezeptor-antagonist-triterpen-derivat n

Info

Publication number
ATE165811T1
ATE165811T1 AT95112524T AT95112524T ATE165811T1 AT E165811 T1 ATE165811 T1 AT E165811T1 AT 95112524 T AT95112524 T AT 95112524T AT 95112524 T AT95112524 T AT 95112524T AT E165811 T1 ATE165811 T1 AT E165811T1
Authority
AT
Austria
Prior art keywords
production
receptor antagonist
intermediate products
endothelin receptor
hydrogen
Prior art date
Application number
AT95112524T
Other languages
English (en)
Inventor
Toshiro Konoike
Yoshitaka Araki
Tetsuyoshi Hayashi
Kensuke Sakurai
Takehiko Tozyo
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi & Co filed Critical Shionogi & Co
Application granted granted Critical
Publication of ATE165811T1 publication Critical patent/ATE165811T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J63/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/01Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/30Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by doubly-bound oxygen atoms
    • C07C233/33Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by doubly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/08Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/18Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by doubly-bound oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J63/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C07J63/008Expansion of ring D by one atom, e.g. D homo steroids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT95112524T 1993-06-11 1994-06-09 Zwischenprodukte für die herstellung von endothelinrezeptor-antagonist-triterpen-derivat n ATE165811T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP14041693 1993-06-11

Publications (1)

Publication Number Publication Date
ATE165811T1 true ATE165811T1 (de) 1998-05-15

Family

ID=15268217

Family Applications (2)

Application Number Title Priority Date Filing Date
AT94304165T ATE142640T1 (de) 1993-06-11 1994-06-09 Triterpenderivate und diese enthaltende endothelinrezeptor antagonisten
AT95112524T ATE165811T1 (de) 1993-06-11 1994-06-09 Zwischenprodukte für die herstellung von endothelinrezeptor-antagonist-triterpen-derivat n

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT94304165T ATE142640T1 (de) 1993-06-11 1994-06-09 Triterpenderivate und diese enthaltende endothelinrezeptor antagonisten

Country Status (11)

Country Link
US (2) US5463107A (de)
EP (2) EP0682009B1 (de)
JP (1) JP2724114B2 (de)
KR (1) KR100201015B1 (de)
CN (2) CN1041938C (de)
AT (2) ATE142640T1 (de)
DE (2) DE69410081T2 (de)
DK (1) DK0628569T3 (de)
ES (2) ES2116663T3 (de)
GR (1) GR3021952T3 (de)
TW (1) TW272974B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW272974B (de) 1993-06-11 1996-03-21 Shionogi & Co
DE69629195T2 (de) * 1995-06-02 2004-05-06 Shionogi & Co., Ltd. Inhibitor von gehirnödemen
WO1997027314A1 (fr) * 1996-01-23 1997-07-31 Shionogi & Co., Ltd. Processus de production d'analogues d'acide oleanolique par la culture de racine pileuse
JP2007217438A (ja) * 2001-07-17 2007-08-30 Shionogi & Co Ltd 注射用医薬製剤
TWI232102B (en) * 2001-07-17 2005-05-11 Shionogi & Co A pharmaceutical formulation for injection
EP1489091A4 (de) * 2002-03-22 2009-06-17 Shionogi & Co Verfahren zur herstellung eines triterpenderivats
WO2004108163A1 (ja) * 2003-06-04 2004-12-16 Shionogi & Co., Ltd. 低帯電性粉末の製造方法
TWI335335B (en) * 2004-03-24 2011-01-01 Shionogi & Co A novel crystal of a triterpene derivative
WO2005110958A1 (ja) 2004-05-14 2005-11-24 Shionogi & Co., Ltd. 過酸化水素およびタングステン触媒を用いたアルコールの酸化反応
JPWO2006077801A1 (ja) * 2005-01-18 2008-06-19 塩野義製薬株式会社 ミリセロン誘導体の製造方法
WO2007072845A1 (ja) * 2005-12-21 2007-06-28 Shionogi & Co., Ltd. 虚血性脳卒中治療薬または治療方法
WO2007103727A2 (en) * 2006-03-03 2007-09-13 Savipu Pharmaceuticals Triterpene derivatives for the treatment of cancer and inflammatory disease by inhibition of nf-kb
US7323476B2 (en) * 2006-03-03 2008-01-29 Savipu Pharmaceuticals Myriceric acid derivatives for the treatment of cancer, cardiovascular and inflammatory diseases
US20070207989A1 (en) * 2006-03-03 2007-09-06 Savipu Pharmaceuticals Diterpene derivatives for the treatment of cardiovascular, cancer and inflammatory diseases
US20070243273A1 (en) * 2006-04-12 2007-10-18 Savipu Pharmaceuticals Reduction of the Deleterious Effects of Tobacco Smoking
US20080017207A1 (en) * 2006-07-18 2008-01-24 Savipu Pharmaceuticals Reduction of the Deleterious Effects of Tobacco Smoking by the Induction of Phase 2 Enzymes by Nerf2
US20080187608A1 (en) * 2007-02-05 2008-08-07 Savipu Pharmaceuticals Enriched fractions from clary sage for the treatment of cancer, cardiovascular and inflammatory diseases
US20090022821A1 (en) * 2007-07-17 2009-01-22 Inderjit Kumar Dev Compositions from wax myrtle for the treatment of cancer, cardiovascular and inflammatory diseases

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE164588T1 (de) * 1991-01-29 1998-04-15 Shionogi & Co Triterpenderivat
TW272974B (de) 1993-06-11 1996-03-21 Shionogi & Co

Also Published As

Publication number Publication date
CN1070183C (zh) 2001-08-29
ES2116663T3 (es) 1998-07-16
US5587505A (en) 1996-12-24
CN1215725A (zh) 1999-05-05
GR3021952T3 (en) 1997-03-31
DE69410081D1 (de) 1998-06-10
EP0682009B1 (de) 1998-05-06
JPH0753484A (ja) 1995-02-28
US5463107A (en) 1995-10-31
DE69400506T2 (de) 1997-02-13
DE69400506D1 (de) 1996-10-17
EP0682009A2 (de) 1995-11-15
TW272974B (de) 1996-03-21
EP0628569B1 (de) 1996-09-11
ES2094622T3 (es) 1997-01-16
CN1106368A (zh) 1995-08-09
KR950000663A (ko) 1995-01-03
KR100201015B1 (ko) 1999-06-15
DK0628569T3 (da) 1996-09-30
EP0628569A1 (de) 1994-12-14
JP2724114B2 (ja) 1998-03-09
EP0682009A3 (de) 1997-02-05
ATE142640T1 (de) 1996-09-15
CN1041938C (zh) 1999-02-03
DE69410081T2 (de) 1998-10-08

Similar Documents

Publication Publication Date Title
ATE165811T1 (de) Zwischenprodukte für die herstellung von endothelinrezeptor-antagonist-triterpen-derivat n
ATE164588T1 (de) Triterpenderivat
ATE286880T2 (de) Verwendung von fluprostenolisopropylester zur herstellung eines arzneimittels zur behandlung von glaukom und okularer hypertension
IT1229570B (it) Derivati fluorurati di acidi biliari, loro preparazione e composizioni farmaceutiche che li contengono.
ATE147071T1 (de) 1,4-disubstituierte piperidinderivate, ihre herstellung und therapeutische verwendung
ES2087038A1 (es) Nuevas piperidinas con actividad antagonista del paf.
FI906296A0 (fi) Nya metylenbisfosfonsyrederivat.
DE3765142D1 (de) Halogenide des esters aus 2-n,n,n-dimethyl-alkyl-amino-aethanol mit substituierter essigsaeure, sowie diese enthaltende arzneimittel mit entzuendungshemmender und antiseptischer wirkung.
HUT50464A (en) Process for producing phenothiazin derivatives
NZ334119A (en) Use of pentynoic acid derivatives as neurotrophic and antiproliferative agents
IL163344A (en) 2-(4-(3-cyclopentyloxy-4-difluoromethoxyphenyl)-4-cyanopiperidin-1-yl)acetic acid derivative compounds, process for their synthesis and compositions comprising the compounds as the active ingredient
IE781545L (en) Benzimidazole-2-derivatives.
ES2130403T3 (es) Derivado del acido quinolin-3-acetico, procedimiento para su produccion, y uso del mismo.
FI860098A (fi) Nya piperazinderivat, foerfarande foer deras framstaellning och farmaceutiska kompositioner som innehaoller dessa foereningar som aktiv ingrediens.
ATE92461T1 (de) Gegen die zerebrale insuffizienz wirksame verbindungen.
ATE173921T1 (de) Verwendung von deoxyspergualin zur herstellung eines arzneimittels zur behandlung von entzündlich-hyperreaktiven erkrankungen
ES2073919T3 (es) Derivados de piperidina 1,3,4-trisubstituidos, su obtencion y empleo.
ATE157665T1 (de) 9-amino-pyridazino 4',5' : 3,4>pyrrolo- 2,1- a>isochinoline und deren verwendung für die herstellung von pharmazeutischen zubereitungen
EP0601181A4 (en) Benzofuran derivative and pharmaceutical composition.
MX9800368A (es) Derivados de piperidina de difenilmetileno.
DE59605367D1 (de) Verwendung des alpha,alpha-diphenylessigsäure-4-(n-methyl-piperidyl)esters als spasmoanalgetikum

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee